ZA200108001B - Processes for making pharmaceutical oral ECB formulations and compositions. - Google Patents
Processes for making pharmaceutical oral ECB formulations and compositions.Info
- Publication number
- ZA200108001B ZA200108001B ZA200108001A ZA200108001A ZA200108001B ZA 200108001 B ZA200108001 B ZA 200108001B ZA 200108001 A ZA200108001 A ZA 200108001A ZA 200108001 A ZA200108001 A ZA 200108001A ZA 200108001 B ZA200108001 B ZA 200108001B
- Authority
- ZA
- South Africa
- Prior art keywords
- ecb
- formulations
- compositions
- processes
- pharmaceutical oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12269399P | 1999-03-03 | 1999-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200108001B true ZA200108001B (en) | 2003-06-25 |
Family
ID=22404178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200108001A ZA200108001B (en) | 1999-03-03 | 2001-09-28 | Processes for making pharmaceutical oral ECB formulations and compositions. |
Country Status (12)
Country | Link |
---|---|
US (1) | US6821951B2 (fr) |
EP (1) | EP1156784A1 (fr) |
JP (1) | JP2002538097A (fr) |
KR (1) | KR20010112302A (fr) |
CN (1) | CN1345230A (fr) |
AU (1) | AU771727B2 (fr) |
BR (1) | BR0008713A (fr) |
CA (1) | CA2362482A1 (fr) |
HK (1) | HK1040369A1 (fr) |
IL (1) | IL145188A0 (fr) |
WO (1) | WO2000051567A1 (fr) |
ZA (1) | ZA200108001B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743777B1 (en) * | 1992-03-19 | 2004-06-01 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
JP2003511345A (ja) | 1998-12-09 | 2003-03-25 | イーライ リリー アンド カンパニー | Echinocandinシクロペプチド化合物の精製 |
AU767956B2 (en) | 1999-03-03 | 2003-11-27 | Eli Lilly And Company | Formation and anion-exchange of crystalline echinocandin ammonium salts |
WO2000051567A1 (fr) | 1999-03-03 | 2000-09-08 | Eli Lilly And Company | Procedes permettant de preparer des compositions et des formulations pharmaceutiques orales d'echinocandine b |
AU776782C (en) * | 1999-03-03 | 2005-04-07 | Eli Lilly And Company | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
EP1157030B1 (fr) | 1999-03-03 | 2003-08-27 | Eli Lilly And Company | Complexes d'echinocandine/glucide |
TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
AUPR272901A0 (en) * | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
US6991800B2 (en) * | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
WO2004026950A2 (fr) * | 2002-08-14 | 2004-04-01 | E.I. Du Pont De Nemours And Company | Poudre fluide solide presentant une charge liquide elevee |
CA2490601C (fr) * | 2003-12-29 | 2006-05-02 | Ferring B.V. | Methode de preparation d'une forme pharmaceutique solide de desmopressine |
PT2680873T (pt) | 2011-03-03 | 2017-11-01 | Cidara Therapeutics Inc | Agentes antifúngicos e suas utilizações |
ES2767576T3 (es) | 2012-03-19 | 2020-06-18 | Cidara Therapeutics Inc | Regímenes de dosificación para los compuestos de la clase de las equinocandinas |
CN103330932B (zh) * | 2013-04-26 | 2015-12-23 | 江苏豪森药业股份有限公司 | 一种米卡芬净或其盐的药物组合物 |
CN108883152A (zh) | 2016-01-08 | 2018-11-23 | 奇达拉治疗公司 | 防止和治疗肺孢子虫感染的方法 |
MA43825A (fr) | 2016-03-16 | 2021-04-07 | Cidara Therapeutics Inc | Schémas posologiques pour le traitement d'infections fongiques |
CA3069423A1 (fr) | 2017-07-12 | 2019-01-17 | Cidara Therapeutics, Inc. | Formulations pour le traitement des infections fongiques |
CN109574811B (zh) * | 2018-11-22 | 2021-12-24 | 中山大学 | 一种阿尼芬净侧链中间体对戊氧基三联苯甲酸的制备方法 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3293482A (en) | 1962-06-21 | 1966-12-20 | Rca Corp | Plural output traveling wave tube |
JPS5134916B2 (fr) | 1974-03-06 | 1976-09-29 | ||
US4293483A (en) | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4304716A (en) | 1979-12-13 | 1981-12-08 | Eli Lilly And Company | S 31794/F-1 Nucleus |
US4320052A (en) | 1979-12-13 | 1982-03-16 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
CA1170598A (fr) | 1979-12-13 | 1984-07-10 | Bernard J. Abbott | Methode de preparation de noyaux peptidiques cycliques |
US4293482A (en) | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | A-30912A Nucleus |
US4293489A (en) | 1979-12-13 | 1981-10-06 | Eli Lilly And Company | Derivatives of A-30912A nucleus |
US4299763A (en) | 1979-12-13 | 1981-11-10 | Eli Lilly And Company | A-30912B Nucleus |
US4876241A (en) | 1987-05-22 | 1989-10-24 | Armour Pharmaceutical Company | Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants |
DK173802B1 (da) | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
US5166135A (en) | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
US5202309A (en) | 1989-06-30 | 1993-04-13 | Merck & Co., Inc. | Antibiotic cyclopeptide fermentation product |
JPH03240727A (ja) | 1990-02-15 | 1991-10-28 | Toyo Jozo Co Ltd | ニューモシスチス・カリニ肺炎治療剤 |
CA2037957A1 (fr) | 1990-03-12 | 1991-09-13 | Merck & Co., Inc. | Composes de cyclohexapeptides n-acyles |
US5310726A (en) | 1990-03-19 | 1994-05-10 | Merck & Co., Inc. | Lipopeptide compounds |
ATE140728T1 (de) | 1990-06-07 | 1996-08-15 | Lilly Co Eli | Lipopeptid deacylase |
IE912046A1 (en) | 1990-06-18 | 1991-12-18 | Fujisawa Pharmaceutical Co | New polypeptide compound and a process for preparation¹thereof |
US5198421A (en) | 1991-04-26 | 1993-03-30 | Merck & Co., Inc. | Phosphorylated cyclic lipopeptide |
JPH05271097A (ja) | 1991-10-07 | 1993-10-19 | Asahi Chem Ind Co Ltd | アクレアシン類の可溶化剤および医薬組成物 |
IL122315A (en) | 1992-03-19 | 2002-03-10 | Lilly Co Eli | Cyclic peptides and antifungal pharmaceutical compositions containing them |
US6384013B1 (en) | 1992-03-19 | 2002-05-07 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
US5965525A (en) | 1992-03-19 | 1999-10-12 | Eli Lilly And Company | Cyclic peptide antifungal agents |
EP0589074B1 (fr) | 1992-09-22 | 2001-11-21 | Takeo Dr. Takayanagi | Complexes d'hydrates de carbone pour la destruction de cellules cancéreuses |
JPH06172205A (ja) | 1992-12-11 | 1994-06-21 | Asahi Chem Ind Co Ltd | アクレアシン類含有脂肪乳剤 |
US5383324A (en) | 1993-04-23 | 1995-01-24 | Baxter International Inc. | Method for manufacturing and storing stable bicarbonate solutions |
US6268338B1 (en) * | 1993-04-30 | 2001-07-31 | Merck & Co., Inc. | Cyclohexapeptidyl amine compounds |
US5541160A (en) | 1994-04-04 | 1996-07-30 | Merck & Co., Inc. | Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use |
US5646111A (en) | 1995-04-07 | 1997-07-08 | Eli Lilly And Company | Cyclic peptide antifungal Agents |
US5652213A (en) | 1995-05-26 | 1997-07-29 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5786325A (en) | 1995-05-26 | 1998-07-28 | Eli Lilly And Company | Cyclic peptide antifungal agents and methods of making and using |
US5629290A (en) | 1995-05-26 | 1997-05-13 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5618787A (en) | 1995-05-26 | 1997-04-08 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5629289A (en) | 1995-07-25 | 1997-05-13 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5693611A (en) | 1996-02-01 | 1997-12-02 | Eli Lilly And Company | Cyclic peptide antifungal agents |
AU1851797A (en) | 1996-02-01 | 1997-08-22 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US6245349B1 (en) | 1996-02-23 | 2001-06-12 | éLAN CORPORATION PLC | Drug delivery compositions suitable for intravenous injection |
US5696084A (en) * | 1996-08-16 | 1997-12-09 | Abbott Laboratories | Amino-lipopetide antifungal agents |
AU8687798A (en) | 1997-08-04 | 1999-02-22 | Eli Lilly And Company | Cyclic peptide antifungal agents |
US5972996A (en) * | 1997-08-22 | 1999-10-26 | Merck & Co., Inc. | 4-cyano-4-deformylsordarin derivatives |
CA2255140A1 (fr) | 1997-12-23 | 1999-06-23 | Eli Lilly And Company | Domaine de fixation de l'echinocandine de la 1,3-.beta.-glucane synthase |
US6323176B1 (en) | 1998-02-25 | 2001-11-27 | Eli Lilly And Company | Cyclic peptide antifungal agents |
DE69923460T2 (de) | 1998-08-20 | 2007-01-11 | Eli Lilly And Co., Indianapolis | Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen |
CA2340647A1 (fr) | 1998-08-28 | 2000-03-09 | Eli Lilly And Company | Complexes boronates reversibles/peptides cycliques a 1,2-cis-diol |
JP2003511345A (ja) | 1998-12-09 | 2003-03-25 | イーライ リリー アンド カンパニー | Echinocandinシクロペプチド化合物の精製 |
WO2000035945A1 (fr) | 1998-12-16 | 2000-06-22 | Eli Lilly And Company | Agents antifongiques de peptide cyclique possedant un substituant sucre |
JP2002535248A (ja) | 1998-12-16 | 2002-10-22 | イーライ リリー アンド カンパニー | 環式ペプチド抗真菌剤 |
EP1157030B1 (fr) * | 1999-03-03 | 2003-08-27 | Eli Lilly And Company | Complexes d'echinocandine/glucide |
AU776782C (en) | 1999-03-03 | 2005-04-07 | Eli Lilly And Company | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
AU767956B2 (en) | 1999-03-03 | 2003-11-27 | Eli Lilly And Company | Formation and anion-exchange of crystalline echinocandin ammonium salts |
WO2000051567A1 (fr) | 1999-03-03 | 2000-09-08 | Eli Lilly And Company | Procedes permettant de preparer des compositions et des formulations pharmaceutiques orales d'echinocandine b |
US6258821B1 (en) | 1999-04-26 | 2001-07-10 | Medimmune Oncology, Inc. | Compositions comprising trimetrexate and methods of their synthesis and use |
-
2000
- 2000-03-02 WO PCT/US2000/005547 patent/WO2000051567A1/fr not_active Application Discontinuation
- 2000-03-02 AU AU33934/00A patent/AU771727B2/en not_active Ceased
- 2000-03-02 JP JP2000602036A patent/JP2002538097A/ja not_active Withdrawn
- 2000-03-02 KR KR1020017011216A patent/KR20010112302A/ko not_active Application Discontinuation
- 2000-03-02 CA CA002362482A patent/CA2362482A1/fr not_active Abandoned
- 2000-03-02 CN CN00805698A patent/CN1345230A/zh active Pending
- 2000-03-02 BR BR0008713-0A patent/BR0008713A/pt not_active IP Right Cessation
- 2000-03-02 EP EP00912160A patent/EP1156784A1/fr not_active Withdrawn
- 2000-03-02 IL IL14518800A patent/IL145188A0/xx unknown
-
2001
- 2001-08-29 US US09/942,435 patent/US6821951B2/en not_active Expired - Fee Related
- 2001-09-28 ZA ZA200108001A patent/ZA200108001B/xx unknown
-
2002
- 2002-03-11 HK HK02101824.8A patent/HK1040369A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1156784A1 (fr) | 2001-11-28 |
CA2362482A1 (fr) | 2000-09-08 |
US6821951B2 (en) | 2004-11-23 |
IL145188A0 (en) | 2002-06-30 |
KR20010112302A (ko) | 2001-12-20 |
WO2000051567A8 (fr) | 2002-05-30 |
JP2002538097A (ja) | 2002-11-12 |
HK1040369A1 (zh) | 2002-06-07 |
AU3393400A (en) | 2000-09-21 |
US20020151474A1 (en) | 2002-10-17 |
WO2000051567A1 (fr) | 2000-09-08 |
CN1345230A (zh) | 2002-04-17 |
BR0008713A (pt) | 2001-12-26 |
AU771727B2 (en) | 2004-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
HUP0103341A3 (en) | Azetidine derivatives, preparation and pharmaceutical compositions thereof | |
HK1045650A1 (en) | Pharmaceutical composition. | |
HUP0202495A3 (en) | Stable medicinal compositions for oral use | |
GB0028088D0 (en) | Pharmaceutical compositions | |
GB0001662D0 (en) | Pharmaceutical compositions | |
HK1044476A1 (en) | Medicinal compositions | |
HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
ZA200108001B (en) | Processes for making pharmaceutical oral ECB formulations and compositions. | |
HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
HUP0203597A3 (en) | Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use | |
GB9923436D0 (en) | Pharmaceutical compositions | |
HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
EP1166786A4 (fr) | Compositions medicamenteuses | |
MXPA01012478A (es) | Formulaciones farmaceuticas mejoradas. | |
ZA200308221B (en) | Pharmaceutical compositions for oral and topical administration. | |
ZA200000857B (en) | Pharmaceutical composition. | |
GB9904163D0 (en) | Pharmaceutical compositions | |
GB9911017D0 (en) | Pharmaceutical compositions | |
AU1732401A (en) | Medicinal compositions for oral use | |
EP1173216A4 (fr) | Formulations pharmaceutiques | |
HK1056564A1 (en) | Pharmaceutical compositions containing oligosaccharides and preparation thereof. | |
HK1052168A1 (en) | N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them. | |
GB9904911D0 (en) | Pharmaceutical compositions |